Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Continuous glucose monitoring: long live the revolution!

Literature DB >> 19092785

Continuous glucose monitoring: long live the revolution!

Frank Waldron-Lynch¹, Kevan C Herold.

Abstract

Entities: Chemical

Mesh：

Year: 2008 PMID： 19092785 DOI： 10.1038/ncpendmet1044

Source DB: PubMed Journal: Nat Clin Pract Endocrinol Metab ISSN： 1745-8366

× No keyword cloud information.

9 in total

1. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring.

Authors: Dorothee Deiss; Jan Bolinder; Jean-Pierre Riveline; Tadej Battelino; Emanuele Bosi; Nadia Tubiana-Rufi; David Kerr; Moshe Phillip
Journal: Diabetes Care Date: 2006-12 Impact factor: 19.112

Review 2. Real-time continuous glucose monitoring.

Authors: Bruce Buckingham; Kimberly Caswell; Darrell M Wilson
Journal: Curr Opin Endocrinol Diabetes Obes Date: 2007-08 Impact factor: 3.243

Review 3. Use of continuous glucose monitoring in patients with type 1 diabetes.

Authors: Samuel L Ellis; Ramachandra G Naik; Kate Gemperline; Satish K Garg
Journal: Curr Diabetes Rev Date: 2008-08

4. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors: D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal: N Engl J Med Date: 1993-09-30 Impact factor: 91.245

5. The transition to young adulthood in youth with type 1 diabetes on intensive treatment.

Authors: Glendessa Insabella; Margaret Grey; George Knafl; William Tamborlane
Journal: Pediatr Diabetes Date: 2007-08 Impact factor: 4.866

6. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors:
Journal: Lancet Date: 1998-09-12 Impact factor: 79.321

Review 7. Sensor-augmented pump therapy in type 1 diabetes.

Authors: Stuart A Weinzimer; William V Tamborlane
Journal: Curr Opin Endocrinol Diabetes Obes Date: 2008-04 Impact factor: 3.243

8. Continuous glucose monitoring and intensive treatment of type 1 diabetes.

Authors: William V Tamborlane; Roy W Beck; Bruce W Bode; Bruce Buckingham; H Peter Chase; Robert Clemons; Rosanna Fiallo-Scharer; Larry A Fox; Lisa K Gilliam; Irl B Hirsch; Elbert S Huang; Craig Kollman; Aaron J Kowalski; Lori Laffel; Jean M Lawrence; Joyce Lee; Nelly Mauras; Michael O'Grady; Katrina J Ruedy; Michael Tansey; Eva Tsalikian; Stuart Weinzimer; Darrell M Wilson; Howard Wolpert; Tim Wysocki; Dongyuan Xing
Journal: N Engl J Med Date: 2008-09-08 Impact factor: 91.245

9. A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial.

Authors: Eric S Kilpatrick; Alan S Rigby; Stephen L Atkin
Journal: Diabetes Care Date: 2008-07-23 Impact factor: 17.152

9 in total

5 in total

Review 1. Immunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetes.

Authors: Frank Waldron-Lynch; Kevan C Herold
Journal: Nat Rev Drug Discov Date: 2011-06 Impact factor: 84.694

Review 2. Semi-Implantable Bioelectronics.

Authors: Jiaru Fang; Shuang Huang; Fanmao Liu; Gen He; Xiangling Li; Xinshuo Huang; Hui-Jiuan Chen; Xi Xie
Journal: Nanomicro Lett Date: 2022-05-28